The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.
Read More
Getting a head start before the next pandemic, SAS has won a contract from the state of Texas to develop a series of public health dashboards for use in tracking influenza.
Read More
Seqirus, which is expanding its Holly Springs facility, extended a partnership with BARDA to provide vaccinations against influenza strains, now and in future.
Read More
A report by an expert panel, arguing that a comprehensive, coordinated approach is required to enhance global influenza vaccine supply chain infrastructure, manufacturing, distribution and administration.
Read More
Seqirus will develop two vaccines against the seasonal flu from its Holly Springs manufacturing facility, and has won a multi-year federal contract for $34.95 million to do so.
Read More
The COVID pandemic had one healthy result, if you can call it that. The flu has virtually disappeared in the U.S. as pandemic precautions led to the lowest flu infections ever recorded.
Read More
It’s all part of a national drive to develop a longer-lasting, more broadly protective vaccine to replace the seasonal flu shot.
Read More
The chances of a global pandemic are growing — and we are all dangerously under prepared, according to the World Health Organization
Read More
The FDA approves the advanced flu vaccine process at a Holly Springs facility in NC, making increased production possible.
Read More
